Back to News
Market Impact: 0.3

Validea Detailed Fundamental Analysis

CORNDAQ
Company FundamentalsAnalyst InsightsCapital Returns (Dividends / Buybacks)Derivatives & VolatilityHealthcare & Biotech
Validea Detailed Fundamental Analysis

Validea's guru fundamental report assigns Cencora Inc. (COR), a large-cap growth stock in the Major Drugs industry, an 87% rating via Pim van Vliet's Multi-Factor Investor model. This strategy targets low volatility, strong momentum, and high net payout yields. While COR passes key low-volatility criteria, its neutral performance in momentum and net payout yield suggests it warrants 'some interest' for risk-averse portfolios, rather than strong conviction, within this specific quantitative framework.

Analysis

Cencora Inc. (COR), a large-cap growth stock in the Major Drugs industry, has been assigned an 87% rating by Validea's Multi-Factor Investor model, based on the strategy of Pim van Vliet. This quantitative model prioritizes stocks with a combination of low volatility, strong momentum, and high net payout yields. COR's favorable rating is primarily driven by its low-risk characteristics, as it successfully passes the model's "STANDARD DEVIATION" test. However, the profile is mixed, with the stock receiving a "NEUTRAL" rating for both "TWELVE MINUS ONE MOMENTUM" and "NET PAYOUT YIELD". While the final rank is a "PASS," the 87% score indicates "some interest" rather than the "strong interest" designated for scores above 90%, reflecting that while COR meets the critical low-volatility requirement, it does not currently exhibit strength in the other two core factors of this specific investment strategy.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo

Market Sentiment